Citation Impact
Citing Papers
Maximum Likelihood from Incomplete Data Via the EM Algorithm
1977 Standout
Statistics and Causal Inference
1986 Standout
Bayes Factors
1995 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Use of mass media campaigns to change health behaviour
2010 Standout
Permutation Tests for Multiple Loci Affecting a Quantitative Character
1996
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
A mitochondrial genome sequence of a hominin from Sima de los Huesos
2013 StandoutNatureNobel
Machine learning for molecular and materials science
2018 StandoutNature
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Community-based Health Intervention Trials: An Overview of Methodological Issues
2002
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
2004 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Radioimmunoassay in Gastroenterology
1972 StandoutNobel
Amino Acid Metabolism in Mammalian Cell Cultures
1959 StandoutScience
Sites of origin and removal of blood ammonia formed during glycine infusion: effect of L-arginine.
1958 StandoutNobel
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Effect of L-arginine on elevated blood ammonia levels in man
1957 StandoutNobel
Estimation of the probability of an event as a function of several independent variables
1967
NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE
1964
Marrow Transplantation for Treatment of Aplastic Anemia
1977 StandoutNobel
The central role of the propensity score in observational studies for causal effects
1983 Standout
Regression Models and Life-Tables
1972 Standout
Radioimmunoassay of Human Plasma Thyrotropin*
1965
Rectangular Confidence Regions for the Means of Multivariate Normal Distributions
1967 Standout
Agonist versus antagonist binding to alpha-adrenergic receptors.
1980 StandoutNobel
Recursive partitioning for heterogeneous causal effects
2016 StandoutNobel
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
1974
Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide.
1982 StandoutNobel
Ver�nderungen des Blutzuckers und der Plasmainsulinkonzentration nach Stimulierung der endogenen Sekretinfreisetzung
1969
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
RE: “ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES”
1977
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Evaluative and hedonic wellbeing among those with and without children at home
2014 StandoutNobel
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
1987 Standout
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 Standout
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Herpesvirus Type 2: Association with Carcinoma of the Cervix
1968 Science
The Future of Data Analysis
1962
A Nonproportional Hazards Weibull Accelerated Failure Time Regression Model
1991
Carboxypeptidase in blood and other fluids—I.
1964
Plasma insulin in man
1960 StandoutNobel
Procedures for Detecting Outlying Observations in Samples
1969 Standout
Heritable True Fitness and Bright Birds: A Role for Parasites?
1982 StandoutScience
An updated coronary risk profile. A statement for health professionals.
1991 Standout
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Estimating causal effects of treatments in randomized and nonrandomized studies.
1974 Standout
Studies on the metabolism of amino acids and related compounds in vivo. III. Prevention of ammonia toxicity by arginine and related compounds
1956
Aplastic Anemia
1982 StandoutNobel
Effect of Arginine and Glutamate on the Removal of Ammonia from the Blood in Normal and Cirrhotic Patients
1957
Idiot's Bayes—Not So Stupid After All?
2001
Enterogastrone Inhibits Eating by Fasted Mice
1967 StandoutScienceNobel
Toxicity and Blood Ammonia Rise Resulting from Intravenous Amino Acid Administration in Man: The Protective Effect of l-Arginine
1957
Sensitivity Analysis in Observational Research: Introducing the E-Value
2017 Standout
STUDIES ON THE PHYSIOLOGY OF HUNGER. I. THE EFFECT OF INTRAVENOUS ADMINISTRATION OF GLUCOSE ON GASTRIC HUNGER CONTRACTIONS IN MAN 1
1956
The prevention of ammonia toxicity by l-arginine and related compounds
1955
Properties of Diagnostic Data Distributions
1976
Population biology of infectious diseases: Part I
1979 StandoutNature
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.
1978 Standout
Reciprocal food sharing in the vampire bat
1984 Nature
Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam
2002
Evolutionary games and spatial chaos
1992 StandoutNature
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
1959 Standout
FAILURE OF ENDOGENOUS STIMULATION OF SECRETIN AND PANCREOZYMIN RELEASE TO INFLUENCE SERUM-INSULIN
1968
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.
1983 StandoutNobel
Studies on the metabolism of amino acids and related compounds in vivo. IV. Blood ammonia and urea levels following intraperitoneal administration of amino acids and ammonium acetate, and the effect of arginine thereon
1956
Implementation of Group Sequential Logrank Tests in a Maximum Duration Trial
1990
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.
1983 StandoutNobel
CHOLESTEROL METABOLISM IN MAN
1955
A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents.
1973
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Fate of Angiotensin I in the Circulation
1968 StandoutNatureNobel
Use of the Logistic Model in Retrospective Studies
1976
The Arginine Requirement of Tissue Cultures
1958
AN ASSAY FOR INSULIN-LIKE ACTIVITY USING RAT ADIPOSE TISSUE
1958
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
The Analysis of Failure Times in the Presence of Competing Risks
1978
Prognosis in Acquired Aplastic Anaemia A Multivariate Statistical Analysis of 80 Cases
1981
Works of Jerome Cornfield being referenced
The Statistical Association Between Smoking and Carcinoma of the Lung
1953
Sequential Trials, Sequential Analysis and the Likelihood Principle
1966
The University Group Diabetes Program
1971
The meaning of bioassay: a comment.
1967
Studies on the metabolism of amino acids and related compounds in vivo. I. Toxicity of essential amino acids, individually and in mixtures, and the protective effect of l-arginine
1956
Smoking and Lung Cancer: Recent Evidence and a Discussion of Some Questions
1959
Cancer of the Lung in Physicians
1953
A Study of Environmental Factors in Carcinoma of the Cervix
1954
Estimation of the Probability of Developing a Disease in the Presence of Competing Risks
1957
SYMPOSIUM ON CHD PREVENTION TRIALS: DESIGN ISSUES IN TESTING LIFE STYLE INTERVENTION
1978
Tables of Percentage Points for the Studentized Maximum Absolute Deviate in Normal Samples*
1955
COMPARATIVE BIOASSAYS AND THE ROLE OF PARALLELISM
1964
A multivariate analysis of the risk of coronary heart disease in Framingham
1967
A Method of Estimating Comparative Rates from Clinical Data. Applications to Cancer of the Lung, Breast, and Cervix
1951
AN IMPROVED ASSAY METHOD FOR THYROTROPHIN USING DEPLETION OF I131FROM THE THYROID OF DAY-OLD CHICKS
1957
The Kinetics of Carboxypeptidase B Activity
1962
Quantitative Relations Between the Oral and Intravenous Glucose Tolerance Curves
1954
Average Values of Mean Squares in Factorials
1956
A Method for Assay of Insulin Using Alloxan Diabetic Hypophysectomized Mouse
1957
Multigroup diagnosis of electrocardiograms
1973
Joint dependence of risk of coronary heart disease on serum cholesterol and systolic blood pressure: a discriminant function analysis.
1998
The toxicity of essential amino acid mixtures with special reference to the protective effect of l-arginine
1955
The toxicity of individual essential amino acids and their diastereomers in rats and the effect on blood sugar levels
1955
Lung Cancer in Women
1956